Labcorp announced an agreement to enter into a strategic relationship with Jefferson Health, the largest health system serving the greater Philadelphia area and Southern New Jersey. When complete, the arrangements between Jefferson and Labcorp will serve to build academic collaborations around teaching and the development of tests. The relationship will expand the scope and productivity of specialty lab testing that is retained by Jefferson, and will further the academic and research missions of Thomas Jefferson University. Jefferson and Labcorp will work together to establish the Innovation Driving Excellence in Academics, or IDEA, initiative, with a goal of advancing testing capabilities and technologies to improve health outcomes. Additionally, the parties will work together to improve healthcare services for underserved communities in Philadelphia and surrounding areas by using advanced population health digital solutions to deliver enhanced efficiency for patients.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on LH:
- Labcorp price target lowered to $275 from $285 at Truist
- Labcorp price target lowered to $240 from $265 at Deutsche Bank
- Labcorp price target lowered to $235 from $260 at Citi
- Labcorp raises FY23 adjusted EPS view $16.25-$17.75 from $16.00-$18.00
- Labcorp reports Q1 adjusted EPS $3.82, consensus $3.96